Medtronic plcMDTNYSE
Loading
Operating cash flow minus capital expenditures
3Y CAGR
-4.6%/yr
vs +13.4%/yr prior
5Y CAGR
-2.9%/yr
Consistent
Acceleration
-18.0pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.18B | -0.3% |
| 2024 | $5.20B | +13.5% |
| 2023 | $4.58B | -23.4% |
| 2022 | $5.98B | +22.4% |
| 2021 | $4.88B | -18.9% |
| 2020 | $6.02B | +2.5% |
| 2019 | $5.87B | +62.4% |
| 2018 | $3.62B | -35.7% |
| 2017 | $5.63B | +34.9% |
| 2016 | $4.17B | - |